As an independent, chemistry-led research, development, and manufacturing partner, we combine rigorous execution and hands-on experience with the agility and care that bigger players can’t match. You deal directly with highly skilled chemists and senior decision-makers who adapt to your needs, respond quickly, and think beyond the brief. Whether you’re scaling a complex molecule for clinic readiness or navigating the unique challenges of diagnostics and materials, we bring cross-sector insight, strategic foresight, and a values-driven approach to every project.

Trusted by long-standing partners and built for whatever’s next, we’re here to flex, scale, and support your every ambition

Type of Drugs Manufactured:

Small Molecule

CDMO Services:

Drug Substance Manufacturing (API);Research & Development;Analytical Development

CDMO Therapeutic Area:

Cardiovascular; Central Nervous System; Dermatology; Diagnostics and Monitoring; Ear Nose Throat and Oral Health; Endocrine and Hormonal; Gastrointestinal and Metabolism; Genito Urinary and Women’s Health; Hematology; Immunology; Infectious Disease; Musculoskeletal System; Nutritional; Oncology; Ophthalmology; Rare and Genetic Disorders; Wounds and Injuries; Pain Symptoms

Number of Facilities:

2

High Potent Products capabilities:

OEB 3 Medium Potency

Facilities Locations:

Europe

Regulatory Approvals for facilities:

UK – MHRA;GMP;ISO 9001